Company patents

CARDIOVALVE LTD.

CARDIOVALVE LTD. exhibits a highly concentrated patent strategy, with 97.1% of its portfolio in Implants & Prosthetics, which saw a significant 50.0% decline in patenting in 2025 and a further 84.6% decline so far in 2026. While Medical Diagnostics & Surgery patents experienced a 40.0% growth in 2024, this category also saw a sharp 71.4% drop in 2025 and a complete cessation so far in 2026, indicating a potential shift away from these areas despite their initial growth.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

68 US filings (since 2023) · 7 categories · 3 themes

Patents

Showing 1-10 of 123

Page 1 of 13